![]() | ![]() |
Formats:
|
||||||||||||||||||||
Systematic pathway analysis using high-resolution fitness profiling of combinatorial gene deletions 1Department of Biochemistry, Stanford University, Stanford, California 94305, USA 2Biological Chemistry and Molecular Pharmacology Department, Harvard, Boston, Massachusetts 02115, USA 3Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario M5S3E1, Canada 4Center for Cancer Systems Biology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115, USA AUTHOR CONTRIBUTIONS R.P.St.O. was involved in every aspect of the study, from experimental design and performance to writing the manuscript. R.M. designed and executed algorithms and performed bioinformatic analysis. J.O. performed genetic experiments and growth curves. M.P. designed custom robotics and automation software. E.F. wrote software and performed database management. R.W.D. contributed intellectually throughout to experimental design and execution. C.N. helped design the experiments and write the manuscript. F.P.R. was involved in data analysis and manuscript preparation. G.G. was involved in every aspect of the study, including manuscript preparation. Correspondence should be addressed to F.P.R. (Email: froth/at/hms.harvard.edu) or G.G. (Email: guri.giaever/at/utoronto.ca) Abstract Systematic genetic interaction studies have illuminated many cellular processes. Here we quantitatively examine genetic interactions among 26 Saccharomyces cerevisiae genes conferring resistance to the DNA-damaging agent methyl methanesulfonate (MMS), as determined by chemogenomic fitness profiling of pooled deletion strains. We constructed 650 double-deletion strains, corresponding to all pairings of these 26 deletions. The fitness of single- and double-deletion strains were measured in the presence and absence of MMS. Genetic interactions were defined by combining principles from both statistical and classical genetics. The resulting network predicts that the Mph1 helicase has a role in resolving homologous recombination–derived DNA intermediates that is similar to (but distinct from) that of the Sgs1 helicase. Our results emphasize the utility of small molecules and multifactorial deletion mutants in uncovering functional relationships and pathway order. Complicating the relationship between genotype and phenotype is the fact that individual alleles sometimes combine to produce surprising phenotypes. The word ‘epistasis’ has been used in distinct ways, in both classical and statistical genetics, to describe this phenomenon1. Theoretical statistical-genetic arguments support the expectation that deleterious fitness effects of mutant alleles in independently functioning genes should combine multiplicatively; in other words, the double-mutant fitness is expected to be the product of the single-mutant fitness values2. The frequency with which this relationship occurs in nature is consequential to theories regarding evolution and the origins of sexual reproduction3, but it remains unresolved after limited study4–6. Departure from the multiplicative model suggests that the corresponding gene products have a functional relationship, the nature of which depends on the ‘direction’ of the departure. Aggravating interactions, or ‘negative epistasis’ (in which the double-mutant fitness is lower than expected; synthetic lethality, in the extreme case), often reflect activities operating in separate but compensatory pathways7. Alleviating interactions, or ‘positive epistasis’ (in which the double-mutant fitness is greater than expected), often result when gene products operate in concert or in series within the same pathway. These interactions (also called ‘diminishing- returns’ interactions2) arise, for example, when a mutation in one gene impairs the function of a whole pathway, thereby concealing the consequence of additional mutations in other members of that pathway. Several experimental studies and their analyses in Saccharomyces cerevisiae have illustrated the value of genome-scale screens for genetic interactions8–20. Screens for synthetic sick or lethal genetic interactions have uncovered numerous functional relationships, identified compensatory protein complexes and pathways, and offered insight into the nature of genetic robustness8–17. Most large-scale genetic interaction screens, however, have been restricted to the discovery of synthetic sick or lethal interactions and have defined such interactions by departure from the expectation that double-mutant strains will have the fitness of the least fit single mutant8,10–12,14,15. Although recent studies have expanded to include the measurement of alleviating interactions, these interactions have not been defined in a consistent way. In one case, a range of interaction types was defined by enumerating all possible ‘greater than’, ‘less than’ and ‘equal to’ relationships among single- and double-mutant invasive growth phenotypes18. In another case, epistasis was defined with the S-score13, which identifies interactions from double mutants whose growth deviates from the median growth of all evaluated double mutants involving a given gene20. A theoretical study19 defined interaction under the multiplicative neutral model2 by using predicted growth rates, but ultimately favored an alternative measure (‘scaled epsilon’). Neither of the latter two measures was evaluated experimentally. Here we have conducted a comprehensive and quantitative analysis of genetic interactions among a target set of genes, focusing on non-essential genes that confer resistance to the DNA-damaging agent MMS. Quantitative fitness analysis identified both aggravating and alleviating interactions on the basis of deviation from a multiplicative model. Because of the quantitative nature of our assay, we could also differentiate among ‘classical genetic’ subclasses of alleviating interactions on the basis of the relative MMS sensitivity of single-and double-deletion strains. We used a systematic, objective and automated analysis of the genetic evidence to derive an interaction network that recapitulates many known features of DNA repair pathways. This interaction network also makes predictions, including a role for the Mph1 helicase in resolving DNA intermediates resulting from homologous recombination. RESULTS Selection, construction and fitness of double-deletion mutants We systematically assessed genetic interactions among a target subset of genes that confer resistance to the compound MMS. These genes were selected on the basis of the results of a chemogenomic fitness screen of pooled homozygous yeast deletion strains21,22 (Fig. 1
The doubling times of single mutants (with and without MMS) ranged from 1.3 h to 8 h, and the average coefficient of variation (CV), calculated from not fewer than five replicates, was 5.2%. Only a modest increase in CV was observed for strains with the most severe growth defects (Supplementary Fig. 1 online). This method provided the sensitivity and precision necessary for distinguishing small differences in growth rate, which were essential for our subsequent analysis (Supplementary Fig. 1). The fitness of each deletion strain was defined by its growth rate relative to that of wild type (calculated as the doubling time of the parental wild-type strain divided by that of the mutant). The average fitness values of single-deletion strains used for further analysis are shown in Figure 2b We used the 26 Kanr haploid deletion strains and 26 Natr haploid deletion strains to construct 650 double-deletion strains. Four of these strains could not be constructed because of genetic linkage between genes. Ten other strains were nonviable (synthetically lethal) and were assigned a fitness of zero. The fitness of the remaining 636 double-deletion strains was measured in YPD media both with and without MMS (see Methods). A benefit of this approach is that each gene pair is represented by two independently constructed double-deletion strains (referred to as the ‘Kanr-Natr’ and ‘Natr - Kanr’ strains). To quantify the robustness of our strain construction and fitness assay, we plotted the fitness (calculated in both the presence and the absence of MMS) of the Kanr-Natr double-deletion strains against that of the Natr-Kanr deletion strains (Fig. 2c Quantitative genetic interactions predict shared function If the deleterious effects of two distinct mutations are truly independent of one another, then their fitness defects are predicted to combine multiplicatively2. In other words, if a strain deleted for gene x has a fitness Wx and a strain deleted for gene y has a fitness Wy, then the fitness of the double mutant strain Wxy is expected to be Wx × Wy. Using the double- and single-deletion fitness values calculated in Figure 2
Given that deviation from neutrality (nonzero ε) suggests a functional relationship, we assessed how well current knowledge of these genes was reflected in the ε values. We examined the distribution of ε value for gene pairs with or without a specific functional link—in other words, gene pairs that either do or do not share a specific gene ontology (GO) term23. Whereas the distribution of ε values for genes without a specific functional link is centered near zero, the ε values of the 35 functionally linked gene pairs are clearly centered away from zero and are predominantly positive (Fig. 3b Prediction of specific functional linkage on the basis of the ε value alone achieved a sensitivity of 80% at a false-positive rate of 20% (Fig. 3c Identification of significant genetic interactions Because two gene pairs with the same ε value may have different susceptibilities to measurement error, we used a Z-test based on estimated errors in fitness measurements of single- and double-deletion strains to detect significant departure (P < 0.01) of each gene pair from the multiplicative model (see Methods). We applied this method to fitness measurements obtained both with and without MMS, and found that the addition of MMS increased the number of both aggravating and alleviating interactions (Fig. 4
Of the 45 gene pairs with significantly positive ε (see below), 24 had a functional link. Of the 21 alleviating interactions that did not have a functional link, many have well-documented interactions including MUS81-MMS4 (ref. 25), SGS1-SHU1, SGS1-SHU2 and SGS1-PSY3 (ref. 26); HPR5-RAD18 and HPR5-RAD5 (ref. 27); RAD5-RAD18 (ref. 28); and SHU1-SHU2 (ref. 29). Most gene pairs in our data set were classified as neutral, even when cells were grown in the presence of MMS. The limited connectivity of alleviating interactions was marked given that the genes studied were already enriched for a common function (conferring resistance to MMS). This observation suggests that the functional information provided by alleviating interactions is specific rather than general. Subclassification of alleviating interactions We focused further on the 45 gene pairs classified as alleviating in MMS, dividing them into five distinct categories based on the relative MMS sensitivity (S; see Methods) of single- and double-deletion strains (Fig. 5a
Coequal relationships suggest that the genes function as cohesive units. For example, if two genes encode distinct subunits of a given protein complex, then we would expect these genes to show a coequal relationship (if neither gene has an additional function and if the protein complex requires both subunits for its function). Nine of the ten coequal interactions that we detected (all but PSY3-HPR5) encode, or are predicted to encode, physically interacting proteins25,26,28,32,33 (Fig. 5b Asymmetric alleviating interactions (where Sx ≠ Sy) can be used to infer the order of biochemical events in a pathway34. For example, the phenotype of an xΔyΔ mutant resembling that of xΔ, but not yΔ, could be explained by protein X operating upstream of protein Y in a pathway (under the positive regulatory model of Avery and Wasserman34). We found that the genetic interactions among five genes central to homologous recombination (RAD51, RAD52, RAD54, RAD55 and RAD57; hereafter termed ‘homologous recombination genes’) can recapitulate the current model for the biochemical steps carried out by their encoded proteins (Fig. 5c The most highly connected module of alleviating interactions involved four genes (SHU1, SHU2, CSM2 and PSY3) that encode members of a protein complex collectively referred to hereafter as the ‘Shu complex’. Notably, we found coequal interactions between all pairs of Shu complex genes. Consistent with a previous report, deletions in each of these four genes partially suppressed the MMS sensitivity of the sgs1Δ strain26.We found that these four deletions also partially suppressed the rad54Δ deletion phenotype (Fig. 5d Predicted role of Mph1 in resolving DNA repair intermediates SGS1 encodes a highly conserved member of the bacterial RecQ helicase family and shares homology with human BLM, which has mutations associated with Bloom’s syndrome37. Sgs1 has been proposed to function closely with the homologous recombination machinery. The synthetic lethality of sgs1Δmus81Δ and sgs1Δmms4Δ double-deletion strains can be rescued by eliminating early steps in homologous recombination (for example, the triple mutant sgs1Δmms4Δrad51Δ is viable38). This observation has led to the hypothesis that the helicase activity of Sgs1 and the endo-nuclease activity of the Mus81-Mms4 complex25 are each important for resolving a common cytotoxic homologous recombination-generated DNA intermediate38. Consistent with this hypothesis, recombination-dependent cruciform structures have been found to accumulate in sgs1Δ cells and to be actively resolved when SGS1 is overexpressed39. Hierarchical clustering of ε values showed that the sgs1Δ strain and the mph1Δ strain share a similar pattern of ε values (Fig. 3a
The expected fitness deviated from expectation for several triple-deletion strains, and the sign of the observed deviation tended to be same in the mph1Δ mms4Δ and mph1Δmus81Δ backgrounds (Fig. 6b Our analysis of double mutants did not identify previously reported interactions between MPH1 and homologous recombination genes41, between MPH1 and Shu complex genes21, or between homologous recombination genes and Shu complex genes26. Even though the ε values for these pairs were consistently positive (Fig. 6a DISCUSSION We have described a comprehensive and quantitative analysis of genetic interactions among 26 non-essential genes involved in resistance to MMS-induced DNA damage. A conceptually simple multiplicative model was used to define genetic interactions between these genes. The validity of this model is supported here by the fact that the fitness defects of gene pairs without functional links usually combine multiplicatively, and that deviation from this model is predictive of shared function. This model has not been applied in previous large-scale genetic interaction studies8,10–12,14,15,18. As a result, some gene pairs might have been previously misinterpreted as being in common or compensatory pathways if the multiplicative neutral model adopted here is correct. In the absence of MMS, our methods classified 12% of gene pairs as aggravating interactions and 6% as alleviating interactions (Fig. 4 The adaptive value of the sexual mode of reproduction has been much debated. The deterministic theory argues that, if aggravating epistasis is prevalent, then sexual reproduction is selective because it enables deleterious mutations to be purged from genomes3. Previous studies aimed at measuring the relative frequencies of alleviating and aggravating interactions have yielded conflicting results4–6. Here, all single-gene deletions produced a quantifiable phenotype relative to wild type (Fig. 1b The relative MMS sensitivities of single and double mutants were used to distinguish distinct subtypes of alleviating genetic interactions. We found that coequal interactions (where Sxy = Sx = Sy) occur between gene pairs that typically have the highest genetic congruence scores (Fig. 3a Genetic congruence between MPH1 and SGS1 led to the hypothesis and observation that the fitness of mph1Δmus81Δ and mph1Δmms4Δ double-deletion strains in MMS can be improved by deleting genes important for homologous recombination and is consistent with the idea that the Mph1 helicase is involved in resolving homologous recombination-dependent toxic DNA intermediates (Fig. 6 Of the roughly 6,000 genes in the yeast genome, fewer than 1,200 are essential for viability under optimal growth conditions (rich medium at 30 °C)22,46. Consistent with studies involving random mutations4,5 and computational studies of yeast metabolism19, most of our gene pairs followed a multiplicative relationship (Fig. 4 METHODS Strains and media All strains were maintained on YPD media47,48. Antibiotic-resistant strains were selected with 200 µg/ml of genetecin (Agri-Bio), 100 µg/ml of nourseothricin (Werner Bioagents) and/or 300 µg/ml of hygromycin B (Agri-Bio). Single-deletion strains were obtained from the yeast deletion collection or were constructed de novo by PCR-based gene replacement49. Double-deletion strains were constructed by the synthetic genetic array (SGA) protocol14 with minor modifications. Cells were transferred manually with a 96-head pin tool and subjected to three rounds of selection before being pinned onto YPD/agar plates, grown for 2 d, and stored at 4 °C. Triple-deletion strains were constructed essentially as above, by crossing single-deletion HygBr MATα haploids to double-deletion Kanr-Natr MATa haploids and by selecting sporulated diploids on double-deletion selection media supplemented with hygromycin B. Double- and triple-deletion strains were reconstructed by sporulating diploid heterozygotes and dissecting tetrads, or by selecting random spores if they met one of the following three criteria: (i) a viable colony was not obtained, (ii) the strain fitness was found to be higher than that of both starting strains (Wxy − max(Wx, Wy) > 0.05), or (iii) the fitness of Kanr-Natr double-deletion strains differed from that of the Natr-Kanr deletion strains Growth assay Individual deletion strains arrayed on YPD/agar were inoculated into 80 µl of YPD using a 96-head pin tool. Cultures were grown to saturation for 20 h at 30 °C and then stored at 4 °C for 4–48 h. The cells were then resuspended by shaking for 15 min, and the optical density at 600 nm (OD600) of cultures was determined using a Tecan GENios microplate reader (Tecan). Cell concentrations were normalized by diluting each culture to a final OD600 of 0.02 with YPD using a Biomek FX Laboratory Automation Workstation (Beckman Coulter). Normalized cultures were grown in 100-µl volumes in 96-well plates in Tecan GENios microplate readers for 24 h. The growth rate of each culture was monitored by measuring the OD600 every 15 min. The doubling time (D) was calculated from the difference between the time tf at an arbitrary maximum OD600 (ODm) and the time ti at a point three generations earlier, divided by the number of generations: D = (tf − ti)/3). The ODm is usually in the exponential growth regime and is approximately the OD600 after five doublings from the beginning of the run. ODm is divided iteratively by 2 to calculate the ODm−3 point at three generations earlier. For growth curves that do not reach saturation or ODm during the growth run, ODm is reassigned to the maximum OD600 of the curve. The fitness (W) of a strain deleted for a given gene x was defined as the ratio of the doubling time (D) of the wild-type strain to the deletion strain (W = Dwt/Dx). Classification of genetic interactions Genetic interaction between a pair of genes (x,y) was defined if the fitness phenotype of the double mutant (Wxy) deviated significantly from that predicted for non-interacting gene pairs (Wx × Wy) under the multiplicative model. For each gene pair, the test used estimates of the mean and s.d. of Wxy derived by treating Kanr-Natr and Natr-Kanr strains as replicates. In addition, the delta method was used to compute the mean and s.d. of the product Wx × Wy on the basis of the means and s.d. of Wx and Wy obtained with the replicates in the single-deletion growth analysis. Gene pairs for which the multiplicative model hypothesis could be rejected (Z-test, α = 0.01) were categorized as genetic interactions. Interacting pairs were further classified as aggravating or alleviating depending on whether the double-deletion fitness phenotype was lesser or greater, respectively, than the product of the single-deletion fitness measurements. Subclassification of alleviating interactions Alleviating interactions were subdivided into five unique categories depending on their MMS sensitivity S, where S = D+MMS/D−MMS. Z-scores were used to measure the proximity of the MMS sensitivity of a double mutant to the sensitivities of the corresponding single mutants, x and y, with the respective formulae: Prediction of shared function Gene ontology (GO) links (‘specific functional links’) were assigned to each gene pair with a specific biological process GO term in common. A GO term was considered to be specific if it is associated with fewer than 30 genes. To assess the value of quantitative genetic interactions in predicting functional links, we used several predictors: ε, genetic congruence (Pearson correlation between ε profiles, calculation for genes x and y excluding εxy, and undefined εxx and εyy values), and Z-scores measuring proximity of the double-deletion MMS sensitivity to the nearest single-deletion MMS sensitivity. The final model combined all of these predictors through a single logistic regression scheme. Regression equations were calculated by using the glmfit and glmval functions in MATLAB (MathWorks). Each model was assessed for its ability to predict functional links by using sixfold cross-validation. The prediction sensitivity or true-positive rate (defined here as the fraction of functionally linked gene pairs correctly predicted to have functional links) and false-positive rate (defined here as the fraction of non-functionally linked gene pairs incorrectly predicted to have functional links) are measured at a series of score thresholds (Fig. 3c Acknowledgment We thank M. Evangelista and S. Pierce for critically reading the manuscript; and B. Andrews, C. Boone, J. Greenblatt, N. Krogan and J. Weissman for discussions. R.P.S. was supported by a postdoctoral fellowship from the Canadian Institutes of Health Research. F.P.R. was supported by grant R01 HG003224 from the National Institutes of Health National Human Genome Research Institute (NIH/NHGRI). This work was supported by a grant from the NHGRI awarded to R.W.D. and G.G. Footnotes Accession numbers The Swiss-Prot accession numbers for the single-deletion strains are as follows: CLA4 (P48562), CSM2 (P40465), CSM3 (Q04659), HPR5 (P12954), MAG1 (P22134), MMS1 (Q06211), MMS4 (P38257), MPH1 (P40562), MUS81 (Q04149), PSY3 (Q12318), RAD5 (P32849), RAD18 (P10862), RAD51 (P25454), RAD52 (P06778), RAD54 (P32863), RAD55 (P38953), RAD57 (P25301), RAD59 (Q12223), RAD61 (Q99359), RTT101 (P47050), RTT107 (P38850), SGS1 (P35187), SHU1 (P38751), SHU2 (P38957), SLX4 (Q12098) and SWC5 (P38326). URLs. Swiss-Prot: http://www.ebi.ac.uk/swissprot Note: Supplementary information is available on the Nature Genetics website. COMPETING INTERESTS STATEMENT The authors declare that they have no competing financial interests. Reprints and permissions information is available online at http://npg.nature.com/reprintsandpermissions References 1. Phillips PC. The language of gene interaction. Genetics. 1998;149:1167–1171. [PubMed] 2. Phillips PC, Otto SP, Whitlock MC. Beyond the Average: the Evolutionary Importance of Gene Interactions and Variability of Epistatic Effects in Epistasis and the Evolutionary Process. New York: Oxford Univ. Press; 2000. pp. 20–38. 3. Kondrashov AS. Deleterious mutations and the evolution of sexual reproduction. Nature. 1998;336:435–440. [PubMed] 4. Szafraniec K, Wloch DM, Sliwa P, Borts RH, Korona R. Small fitness effects and weak genetic interactions between deleterious mutations in heterozygous loci of the yeast Saccharomyces cerevisiae. Genet. Res. 2003;82:19–31. [PubMed] 5. Elena SF, Lenski RE. Test of synergistic interactions among deleterious mutations in bacteria. Nature. 1997;390:395–398. [PubMed] 6. Maisnier-Patin S, et al. Genomic buffering mitigates the effects of deleterious mutations in bacteria. Nat. Genet. 2005;37:1376–1379. [PubMed] 7. Hartman JL, IV, Garvik B, Hartwell L. Principles for the buffering of genetic variation. Science. 2001;291:1001–1004. [PubMed] 8. Davierwala AP, et al. The synthetic genetic interaction spectrum of essential genes. Nat. Genet. 2005;37:1147–1152. [PubMed] 9. Kelley R, Ideker T. Systematic interpretation of genetic interactions using protein networks. Nat. Biotechnol. 2005;23:561–566. [PubMed] 10. Ooi SL, et al. Global synthetic-lethality analysis and yeast functional profiling. Trends Genet. 2006;22:56–63. [PubMed] 11. Ooi SL, Shoemaker DD, Boeke JD. DNA helicase gene interaction network defined using synthetic lethality analyzed by microarray. Nat. Genet. 2003;35:277–286. [PubMed] 12. Pan X, et al. A DNA Integrity network in the yeast Saccharomyces cerevisiae. Cell. 2006;124:1069–1081. [PubMed] 13. Schuldiner M, et al. Exploration of the function and organization of the yeast early secretory pathway through an epistatic miniarray profile. Cell. 2005;123:507–519. [PubMed] 14. Tong AH, et al. Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science. 2001;294:2364–2368. [PubMed] 15. Tong AH, et al. Global mapping of the yeast genetic interaction network. Science. 2004;303:808–813. [PubMed] 16. Wong SL, Zhang LV, Roth FP. Discovering functional relationships: biochemistry versus genetics. Trends Genet. 2005;21:424–427. [PubMed] 17. Wong SL, et al. Combining biological networks to predict genetic interactions. Proc. Natl. Acad. Sci. USA. 2004;101:15682–15687. [PubMed] 18. Drees BL, et al. Derivation of genetic interaction networks from quantitative phenotype data. Genome Biol. 2005;6:R38. [PubMed] 19. Segre D, Deluna A, Church GM, Kishony R. Modular epistasis in yeast metabolism. Nat. Genet. 2005;37:77–83. [PubMed] 20. Collins SR, Schuldiner M, Krogan NJ, Weissman JS. A strategy for extracting and analyzing large-scale quantitative epistatic interaction data. Genome Biol. 2006;7:R63. [PubMed] 21. Lee W, et al. Genome-wide requirements for resistance to functionally distinct DNA-damaging agents. PLoS Genet. 2005;1:e24. [PubMed] 22. Giaever G, et al. Functional profiling of the Saccharomyces cerevisiae genome. Nature. 2002;418:387–391. [PubMed] 23. Ashburner M, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000;25:25–29. [PubMed] 24. Ye P, Peyser BD, Spencer FA, Bader JS. Commensurate distances and similar motifs in genetic congruence and protein interaction networks in yeast. BMC Bioinformatics. 2005;6:270. [PubMed] 25. Kaliraman V, Mullen JR, Fricke WM, Bastin-Shanower SA, Brill SJ. Functional overlap between Sgs1-Top3 and the Mms4-Mus81 endonuclease. Genes Dev. 2001;15:2730–2740. [PubMed] 26. Shor E, Weinstein J, Rothstein R. A genetic screen for top3 suppressors in Saccharomyces cerevisiae identifies SHU1, SHU2, PSY3 and CSM2: four genes involved in error-free DNA repair. Genetics. 2005;169:1275–1289. [PubMed] 27. Friedl AA, Liefshitz B, Steinlauf R, Kupiec M. Deletion of the SRS2 gene suppresses elevated recombination and DNA damage sensitivity in rad5 and rad18 mutants of Saccharomyces cerevisiae. Mutat. Res. 2001;486:137–146. [PubMed] 28. Ulrich HD, Jentsch S. Two RING finger proteins mediate cooperation between ubiquitin-conjugating enzymes in DNA repair. EMBO J. 2000;19:3388–3397. [PubMed] 29. Huang ME, Rio AG, Nicolas A, Kolodner RD. A genomewide screen in Saccharomyces cerevisiae for genes that suppress the accumulation of mutations. Proc. Natl. Acad. Sci. USA. 2003;100:11529–11534. [PubMed] 30. Punnett RC. Mendelism. New York: Macmillan; 1913. 31. Jana S. Simulation of quantitative characters from qualitatively acting genes. I. Nonallelic gene interactions involving two or three loci. Theor. Appl. Genet. 1972;42:119–124. 32. Ito T, et al. A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc. Natl. Acad. Sci. USA. 2001;98:4569–4574. [PubMed] 33. Sung P. Yeast Rad55 and Rad57 proteins form a heterodimer that functions with replication protein A to promote DNA strand exchange by Rad51 recombinase. Genes Dev. 1997;11:1111–1121. [PubMed] 34. Avery L, Wasserman S. Ordering gene function: the interpretation of epistasis in regulatory hierarchies. Trends Genet. 1992;8:312–316. [PubMed] 35. Krogh BO, Symington LS. Recombination proteins in yeast. Annu. Rev. Genet. 2004;38:233–271. [PubMed] 36. Lisby M, Barlow JH, Burgess RC, Rothstein R. Choreography of the DNA damage response: spatiotemporal relationships among checkpoint and repair proteins. Cell. 2004;118:699–713. [PubMed] 37. Ellis NA, et al. The Bloom’s syndrome gene product is homologous to RecQ helicases. Cell. 1995;83:655–666. [PubMed] 38. Fabre F, Chan A, Heyer WD, Gangloff S. Alternate pathways involving Sgs1/Top3, Mus81/ Mms4, and Srs2 prevent formation of toxic recombination intermediates from single-stranded gaps created by DNA replication. Proc. Natl. Acad. Sci. USA. 2002;99:16887–16892. [PubMed] 39. Liberi G, et al. Rad51-dependent DNA structures accumulate at damaged replication forks in sgs1 mutants defective in the yeast ortholog of BLM RecQ helicase. Genes Dev. 2005;19:339–350. [PubMed] 40. Prakash R, et al. Saccharomyces cerevisiae MPH1 gene, required for homologous recombination-mediated mutation avoidance, encodes a 3′ to 5′ DNA helicase. J. Biol. Chem. 2005;280:7854–7860. [PubMed] 41. Schurer KA, Rudolph C, Ulrich HD, Kramer W. Yeast MPH1 gene functions in an error-free DNA damage bypass pathway that requires genes from Homologous recombination, but not from postreplicative repair. Genetics. 2004;166:1673–1686. [PubMed] 42. Meetei AR, et al. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat. Genet. 2005;37:958–963. [PubMed] 43. Bai Y, Symington LSA. Rad52 homolog is required for RAD51-independent mitotic recombination in Saccharomyces cerevisiae. Genes Dev. 1996;10:2025–2037. [PubMed] 44. Klein HL. Mutations in recombinational repair and in checkpoint control genes suppress the lethal combination of srs2Δ with other DNA repair genes in Saccharomyces cerevisiae. Genetics. 2001;157:557–565. [PubMed] 45. McEachern MJ, Haber JE. Break-induced replication and recombinational telomere elongation in yeast. Annu. Rev. Biochem. 2006;75:111–135. [PubMed] 46. Winzeler EA, et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science. 1999;285:901–906. [PubMed] 47. Guthrie C, Fink GR. Guide to Yeast Genetics and Molecular Biology. New York: Academic Press; 1991. 48. Rose MD, Winston F, Heiter P. Methods in Yeast Genetics: a Laboratory Manual. New York, USA: Cold Spring Harbor Laboratory Press, Cold Spring Harbor; 1990. 49. Erdeniz N, Mortensen UH, Rothstein R. Cloning-free PCR-based allele replacement methods. Genome Res. 1997;7:1174–1183. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||
Genetics. 1998 Jul; 149(3):1167-71.
[Genetics. 1998]Nature. 1988 Dec 1; 336(6198):435-40.
[Nature. 1988]Genet Res. 2003 Aug; 82(1):19-31.
[Genet Res. 2003]Nat Genet. 2005 Dec; 37(12):1376-9.
[Nat Genet. 2005]Science. 2001 Feb 9; 291(5506):1001-4.
[Science. 2001]Nat Genet. 2005 Oct; 37(10):1147-52.
[Nat Genet. 2005]Genome Biol. 2006; 7(7):R63.
[Genome Biol. 2006]Proc Natl Acad Sci U S A. 2004 Nov 2; 101(44):15682-7.
[Proc Natl Acad Sci U S A. 2004]Trends Genet. 2006 Jan; 22(1):56-63.
[Trends Genet. 2006]Cell. 2006 Mar 10; 124(5):1069-81.
[Cell. 2006]Genome Biol. 2005; 6(4):R38.
[Genome Biol. 2005]Cell. 2005 Nov 4; 123(3):507-19.
[Cell. 2005]Genome Biol. 2006; 7(7):R63.
[Genome Biol. 2006]Nat Genet. 2005 Jan; 37(1):77-83.
[Nat Genet. 2005]PLoS Genet. 2005 Aug; 1(2):e24.
[PLoS Genet. 2005]Nature. 2002 Jul 25; 418(6896):387-91.
[Nature. 2002]Science. 2001 Dec 14; 294(5550):2364-8.
[Science. 2001]Nat Genet. 2000 May; 25(1):25-9.
[Nat Genet. 2000]Science. 2004 Feb 6; 303(5659):808-13.
[Science. 2004]BMC Bioinformatics. 2005 Nov 9; 6():270.
[BMC Bioinformatics. 2005]Nat Genet. 2005 Jan; 37(1):77-83.
[Nat Genet. 2005]Genes Dev. 2001 Oct 15; 15(20):2730-40.
[Genes Dev. 2001]Genetics. 2005 Mar; 169(3):1275-89.
[Genetics. 2005]Mutat Res. 2001 Jul 12; 486(2):137-46.
[Mutat Res. 2001]EMBO J. 2000 Jul 3; 19(13):3388-97.
[EMBO J. 2000]Proc Natl Acad Sci U S A. 2003 Sep 30; 100(20):11529-34.
[Proc Natl Acad Sci U S A. 2003]Genome Biol. 2005; 6(4):R38.
[Genome Biol. 2005]Genes Dev. 2001 Oct 15; 15(20):2730-40.
[Genes Dev. 2001]Genetics. 2005 Mar; 169(3):1275-89.
[Genetics. 2005]EMBO J. 2000 Jul 3; 19(13):3388-97.
[EMBO J. 2000]Proc Natl Acad Sci U S A. 2001 Apr 10; 98(8):4569-74.
[Proc Natl Acad Sci U S A. 2001]Genes Dev. 1997 May 1; 11(9):1111-21.
[Genes Dev. 1997]Trends Genet. 1992 Sep; 8(9):312-6.
[Trends Genet. 1992]Annu Rev Genet. 2004; 38():233-71.
[Annu Rev Genet. 2004]Cell. 2004 Sep 17; 118(6):699-713.
[Cell. 2004]Genetics. 2005 Mar; 169(3):1275-89.
[Genetics. 2005]Cell. 1995 Nov 17; 83(4):655-66.
[Cell. 1995]Proc Natl Acad Sci U S A. 2002 Dec 24; 99(26):16887-92.
[Proc Natl Acad Sci U S A. 2002]Genes Dev. 2001 Oct 15; 15(20):2730-40.
[Genes Dev. 2001]Genes Dev. 2005 Feb 1; 19(3):339-50.
[Genes Dev. 2005]J Biol Chem. 2005 Mar 4; 280(9):7854-60.
[J Biol Chem. 2005]Genetics. 2004 Apr; 166(4):1673-86.
[Genetics. 2004]Nat Genet. 2005 Sep; 37(9):958-63.
[Nat Genet. 2005]Genes Dev. 1996 Aug 15; 10(16):2025-37.
[Genes Dev. 1996]Proc Natl Acad Sci U S A. 2002 Dec 24; 99(26):16887-92.
[Proc Natl Acad Sci U S A. 2002]Genetics. 2004 Apr; 166(4):1673-86.
[Genetics. 2004]PLoS Genet. 2005 Aug; 1(2):e24.
[PLoS Genet. 2005]Genetics. 2005 Mar; 169(3):1275-89.
[Genetics. 2005]Nat Genet. 2005 Oct; 37(10):1147-52.
[Nat Genet. 2005]Trends Genet. 2006 Jan; 22(1):56-63.
[Trends Genet. 2006]Cell. 2006 Mar 10; 124(5):1069-81.
[Cell. 2006]Science. 2001 Dec 14; 294(5550):2364-8.
[Science. 2001]Science. 2004 Feb 6; 303(5659):808-13.
[Science. 2004]Science. 2004 Feb 6; 303(5659):808-13.
[Science. 2004]Cell. 2005 Nov 4; 123(3):507-19.
[Cell. 2005]Genome Biol. 2005; 6(4):R38.
[Genome Biol. 2005]Nature. 1988 Dec 1; 336(6198):435-40.
[Nature. 1988]Genet Res. 2003 Aug; 82(1):19-31.
[Genet Res. 2003]Nat Genet. 2005 Dec; 37(12):1376-9.
[Nat Genet. 2005]Genes Dev. 2001 Oct 15; 15(20):2730-40.
[Genes Dev. 2001]Genetics. 2005 Mar; 169(3):1275-89.
[Genetics. 2005]EMBO J. 2000 Jul 3; 19(13):3388-97.
[EMBO J. 2000]Proc Natl Acad Sci U S A. 2001 Apr 10; 98(8):4569-74.
[Proc Natl Acad Sci U S A. 2001]Genes Dev. 1997 May 1; 11(9):1111-21.
[Genes Dev. 1997]J Biol Chem. 2005 Mar 4; 280(9):7854-60.
[J Biol Chem. 2005]Annu Rev Biochem. 2006; 75():111-35.
[Annu Rev Biochem. 2006]Nature. 2002 Jul 25; 418(6896):387-91.
[Nature. 2002]Science. 1999 Aug 6; 285(5429):901-6.
[Science. 1999]Genet Res. 2003 Aug; 82(1):19-31.
[Genet Res. 2003]Nature. 1997 Nov 27; 390(6658):395-8.
[Nature. 1997]Nat Genet. 2005 Jan; 37(1):77-83.
[Nat Genet. 2005]Genome Res. 1997 Dec; 7(12):1174-83.
[Genome Res. 1997]Science. 2001 Dec 14; 294(5550):2364-8.
[Science. 2001]PLoS Genet. 2005 Aug; 1(2):e24.
[PLoS Genet. 2005]